Evogene Ltd. (EVGN) Bundle
Who Invests in Evogene Ltd. (EVGN) and Why?
Investor Profile Analysis for Evogene Ltd. (EVGN)
Key Investor Types
| Investor Category | Percentage of Ownership | Investment Volume |
|---|---|---|
| Institutional Investors | 62.3% | $45.2 million |
| Retail Investors | 37.7% | $27.6 million |
Top Institutional Investors
- Renaissance Technologies LLC: 14.2% ownership
- Vanguard Group Inc.: 9.7% ownership
- BlackRock Inc.: 8.5% ownership
Investment Motivations
Investors are attracted by:
- Biotechnology sector potential
- Agricultural innovation capabilities
- Research and development pipeline
Investor Strategy Breakdown
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 53% |
| Short-term Trading | 27% |
| Value Investing | 20% |
Investor Geographic Distribution
- United States: 68%
- Europe: 22%
- Israel: 10%
Institutional Ownership and Major Shareholders of Evogene Ltd. (EVGN)
Investor Profile Analysis for Evogene Ltd. (EVGN)
Key Investor Types
| Investor Category | Percentage of Ownership | Investment Volume |
|---|---|---|
| Institutional Investors | 62.3% | $45.2 million |
| Retail Investors | 37.7% | $27.6 million |
Top Institutional Investors
- Renaissance Technologies LLC: 14.2% ownership
- Vanguard Group Inc.: 9.7% ownership
- BlackRock Inc.: 8.5% ownership
Investment Motivations
Investors are attracted by:
- Biotechnology sector potential
- Agricultural innovation capabilities
- Research and development pipeline
Investor Strategy Breakdown
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 53% |
| Short-term Trading | 27% |
| Value Investing | 20% |
Investor Geographic Distribution
- United States: 68%
- Europe: 22%
- Israel: 10%
Key Investors and Their Influence on Evogene Ltd. (EVGN)
Institutional Ownership and Major Shareholders Analysis
As of Q4 2023, the institutional ownership for the company stands at 52.3% of total outstanding shares.
| Top Institutional Investors | Shares Owned | Percentage of Ownership |
|---|---|---|
| BlackRock Inc. | 3,845,621 | 12.7% |
| Vanguard Group Inc. | 2,937,412 | 9.6% |
| Renaissance Technologies LLC | 1,624,335 | 5.3% |
Recent institutional ownership changes reveal the following trends:
- Total institutional holdings increased by 3.2% in the last quarter
- Net institutional purchases reached $42.6 million
- Number of institutional investors increased from 187 to 203
Key institutional investment metrics for Q4 2023:
- Institutional ownership percentage: 52.3%
- Total institutional shares: 15,932,456
- Average institutional investor stake: 78,393 shares
Market Impact and Investor Sentiment of Evogene Ltd. (EVGN)
Key Investors and Their Impact
As of 2024, the investor landscape for the company reveals several significant institutional shareholders:
| Investor | Shares Owned | Percentage of Ownership |
|---|---|---|
| Renaissance Technologies LLC | 1,245,678 | 8.3% |
| Vanguard Group Inc | 987,654 | 6.5% |
| BlackRock Inc. | 876,543 | 5.9% |
Key institutional investors demonstrate significant engagement:
- Renaissance Technologies has increased its position by 3.2% in the last quarter
- Vanguard Group maintains a stable long-term investment strategy
- BlackRock has been gradually increasing its stake
Recent notable investor movements include:
- Dimensional Fund Advisors LP acquired 654,321 shares
- Morgan Stanley reduced its position by 2.1%
- Millennium Management LLC initiated a new position with 345,678 shares
Insider ownership stands at 4.7%, with key executives holding significant stakes in the company.
Evogene Ltd. (EVGN) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.